Scott D Holmberg

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi The case for earlier treatment of HIV infection
    Scott D Holmberg
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 39:1699-704. 2004
  2. doi Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort
    Scott D Holmberg
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 57:240-6. 2013
  3. doi Molecular epidemiology of health care-associated transmission of hepatitis B and C viruses
    Scott D Holmberg
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, TB, and STD Prevention, Centers for Disease Control and Prevention, CDC Mailstop G 37 1600 Clifton Road, Atlanta, GA 30333, USA
    Clin Liver Dis 14:37-48; vii-viii. 2010
  4. ncbi Protease inhibitors and cardiovascular outcomes in patients with HIV-1
    Scott D Holmberg
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Lancet 360:1747-8. 2002
  5. ncbi Factors associated with maintenance of long-term plasma human immunodeficiency virus RNA suppression
    Scott D Holmberg
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 37:702-7. 2003
  6. ncbi Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women
    Lytt I Gardner
    Centers for Disease Control, Mailstop E 45, Division of HIV AIDS, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 34:320-30. 2003
  7. doi Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010
    Dale J Hu
    Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STDs and TB Prevention NCHHSTP, Atlanta, GA, USA
    Hepatology 58:856-62. 2013
  8. pmc Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999
    Dawn K Smith
    Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of HIV AIDS Prevention, Surveillance and Epidemiology, Atlanta, Georgia, USA
    J Urban Health 80:676-88. 2003
  9. doi Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study (ARTAS) intervention
    Lytt I Gardner
    Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    AIDS Patient Care STDS 23:735-42. 2009
  10. ncbi Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 55:1047-55. 2012

Detail Information

Publications59

  1. ncbi The case for earlier treatment of HIV infection
    Scott D Holmberg
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 39:1699-704. 2004
    ..Given these accumulating data, we believe reconsideration of the "when-to-start" question is timely and justified...
  2. doi Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort
    Scott D Holmberg
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 57:240-6. 2013
    ..Our analysis sought to validate APRI (aspartate aminotransferase [AST]-to-platelet ratio index) and FIB-4, an index from serum fibrosis markers (alanine aminotransferase [ALT], AST, and platelets plus patient age) to stage liver disease...
  3. doi Molecular epidemiology of health care-associated transmission of hepatitis B and C viruses
    Scott D Holmberg
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, TB, and STD Prevention, Centers for Disease Control and Prevention, CDC Mailstop G 37 1600 Clifton Road, Atlanta, GA 30333, USA
    Clin Liver Dis 14:37-48; vii-viii. 2010
    ....
  4. ncbi Protease inhibitors and cardiovascular outcomes in patients with HIV-1
    Scott D Holmberg
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Lancet 360:1747-8. 2002
    ..5, 0.9-47.8). Our findings suggest that, although infrequent, use of protease inhibitors is associated with increased risk of myocardial infarction in patients with HIV-1...
  5. ncbi Factors associated with maintenance of long-term plasma human immunodeficiency virus RNA suppression
    Scott D Holmberg
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 37:702-7. 2003
    ....
  6. ncbi Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women
    Lytt I Gardner
    Centers for Disease Control, Mailstop E 45, Division of HIV AIDS, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 34:320-30. 2003
    ..The rates and risk factors for overall and medical condition-specific hospitalizations in HIV-positive women have not been examined in detail or compared with rates in risk factor-matched HIV-negative women...
  7. doi Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010
    Dale J Hu
    Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STDs and TB Prevention NCHHSTP, Atlanta, GA, USA
    Hepatology 58:856-62. 2013
    ..More state and federal efforts are needed to screen racial/ethnic minorities, especially foreign-born persons, for HBV and link those with infection to care...
  8. pmc Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999
    Dawn K Smith
    Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of HIV AIDS Prevention, Surveillance and Epidemiology, Atlanta, Georgia, USA
    J Urban Health 80:676-88. 2003
    ....
  9. doi Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study (ARTAS) intervention
    Lytt I Gardner
    Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    AIDS Patient Care STDS 23:735-42. 2009
    ..To increase its scope, the intervention may need to be tailored to the specific needs of groups that did not respond well to the intervention...
  10. ncbi Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence
    Philip R Spradling
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 55:1047-55. 2012
    ..Little is known about viral hepatitis testing and infection prevalence among persons in private healthcare organizations (HCOs) in the United States...
  11. pmc Hepatitis E epidemic, Uganda
    Eyasu H Teshale
    Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G37, Atlanta, GA 30333, USA
    Emerg Infect Dis 16:126-9. 2010
    ..This outbreak has progressed to become one of the largest hepatitis E outbreaks in the world. By June 2009, the epidemic had caused illness in >10,196 persons and 160 deaths...
  12. doi Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study
    Anne C Moorman
    Division of Viral Hepatitis National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 56:40-50. 2013
    ..This report describes the cohort selection process, baseline demographics, and insurance, biopsy, hospitalization, and mortality rates...
  13. doi Evolving epidemiology of hepatitis C virus in the United States
    R Monina Klevens
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Clin Infect Dis 55:S3-9. 2012
    ..Infectious disease physicians will increasingly have the responsibility of diagnosing and treating HCV patients. An understanding of how these patients were infected is important for determining whom to screen and treat...
  14. doi The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study)
    Claudia Vellozzi
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Epidemiol 169:642-52. 2009
    ..The SUN Study provides a wealth of data that will inform and improve the clinical management of HIV-infected individuals in the modern era...
  15. doi Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 22:1345-54. 2008
    ..To assess temporal trends in the rates of hospitalizations and associated diagnoses among HIV-infected patients before and during the era of highly active antiretroviral therapy...
  16. pmc Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010
    Rania A Tohme
    Division of Viral Hepatitis, Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
    Am J Public Health 103:112-9. 2013
    ..We estimated rates and determinants of hepatitis C virus (HCV) testing, infection, and linkage to care among US racial/ethnic minorities...
  17. ncbi Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care
    Lytt I Gardner
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 19:423-31. 2005
    ..The Antiretroviral Treatment Access Study (ARTAS) assessed a case management intervention to improve linkage to care for persons recently receiving an HIV diagnosis...
  18. ncbi Detection of acute HIV infections in high-risk patients in California
    Pragna Patel
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 42:75-9. 2006
    ..The detection of acute HIV infection, however, is not routine and requires the use of HIV RNA testing in combination with HIV antibody testing...
  19. pmc Estimating acute viral hepatitis infections from nationally reported cases
    R Monina Klevens
    at the time of the study, all authors were with the Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STDs and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    Am J Public Health 104:482-7. 2014
    ..Because only a fraction of patients with acute viral hepatitis A, B, and C are reported through national surveillance to the Centers for Disease Control and Prevention, we estimated the true numbers...
  20. ncbi Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010
    Reena Mahajan
    Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 58:1055-61. 2014
    ..The number of deaths in hepatitis C virus (HCV)-infected persons recorded on US death certificates has been increasing, but actual rates and causes of death in these individuals have not been well elucidated...
  21. ncbi Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women
    Lytt I Gardner
    Centers for Disease Control and Prevention, Mailstop E 45 Division of HIV AIDS, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 32:203-9. 2003
    ..Data on the incidence and prognostic significance of renal dysfunction in HIV disease are limited...
  22. ncbi Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections
    Kate Buchacz
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    AIDS 18:2075-9. 2004
    ..Syphilitic ulcers are known to facilitate the transmission of HIV infection, but the effect of syphilis infection on HIV viral loads and CD4 cell counts is poorly understood...
  23. ncbi Frequency of discussing HIV prevention and care topics with patients with HIV: influence of physician gender, race/ethnicity, and practice characteristics
    Lytt I Gardner
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Gend Med 5:259-69. 2008
    ..Very limited data are available examining how frequently this discussion is held...
  24. doi The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007
    Kathleen N Ly
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 156:271-8. 2012
    ..The increasing health burden and mortality from hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States are underappreciated...
  25. ncbi Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003
    Pragna Patel
    Centers for Disease Control and Prevention, Emory University, and Northrop Grumman Information Technology, Atlanta, Georgia 30333, USA
    Ann Intern Med 148:728-36. 2008
    ..Persons who are HIV-infected may be at higher risk for certain types of cancer than the general population...
  26. doi Is sexual contact a major mode of hepatitis C virus transmission?
    Rania A Tohme
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA, USA
    Hepatology 52:1497-505. 2010
    ..1-5.7). HIV-infected gay men increase their risk of such transmission in association with practices that lead to mucosal trauma (multiple sexual partners, fisting, use of sex toys) and the presence of genital ulcerative disease...
  27. doi The two faces of hepatitis E virus
    Eyasu H Teshale
    National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 51:328-34. 2010
    ....
  28. ncbi Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    AIDS 19:1423-4. 2005
    ..9-10.6%), compared with 2.1% per year (95% CI 1.3-2.9%) among 2701 non-users (RR 3.0, 95% CI 1.4-6.5). HIV prevention programmes in San Francisco should include efforts to reduce amphetamine use and associated high-risk sexual behaviors...
  29. doi Causes of death and characteristics of decedents with viral hepatitis, United States, 2010
    Kathleen N Ly
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 58:40-9. 2014
    ..This study sought to examine demographic characteristics and the most frequent causes of death among decedents with a viral hepatitis-related death...
  30. pmc Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities
    Richard S Garfein
    Division of HIV AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Urban Health 81:260-7. 2004
    ..Prevention efforts are needed on the West Coast to decrease HIV-associated risk behaviors among IDUs, and further efforts are also needed to reduce HIV incidence on the East Coast...
  31. doi Hepatitis C virus infections from unsafe injection practices at an endoscopy clinic in Las Vegas, Nevada, 2007-2008
    Gayle E Fischer
    National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 51:267-73. 2010
    ..In January 2008, 3 persons with acute hepatitis C who all underwent endoscopy at a single facility in Nevada were identified...
  32. pmc Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010
    Reena Mahajan
    Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Mailstop G37, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    Am J Public Health 103:1445-9. 2013
    ..We examined indications for testing by birth cohort (before 1945, 1945-1965, and after 1965) among persons with past or current HCV...
  33. doi Genotypic distribution of hepatitis B virus (HBV) among acute cases of HBV infection, selected United States counties, 1999-2005
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, TB and STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:751-6. 2011
    ..In the United States, HBV genotyping studies have been conducted for chronic but not acute hepatitis B...
  34. ncbi Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008
    Nicola D Thompson
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Ann Intern Med 150:33-9. 2009
    ....
  35. ncbi Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care
    Lytt I Gardner
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Acquir Immune Defic Syndr 29:69-75. 2002
    ..To evaluate factors associated with use of HIV specialist care by women, and to determine whether medical indications for therapy validate lower rates of antiretroviral use in women not using HIV specialty care...
  36. doi Transmission of hepatitis C virus infection through tattooing and piercing: a critical review
    Rania A Tohme
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention NCHHSTP, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 54:1167-78. 2012
    ..Youths also should be educated on the need to have tattoos and piercings performed under sterile conditions to avoid HCV infection...
  37. ncbi Molecular analysis in support of an investigation of a cluster of HIV-1-infected women
    Kenneth E Robbins
    Center for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 18:1157-61. 2002
    ..In conclusion, phylogenetic analysis of HIV strains in an epidemiologic investigation is highly useful in support of cluster identification, even without sampling from the putative index patient...
  38. ncbi Discordance at human leukocyte antigen-DRB3 and protection from human immunodeficiency virus type 1 transmission
    Shannon L Hader
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, MS E 45, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Infect Dis 185:1729-35. 2002
    ..027). Further investigation of the roles of class II HLAs in HIV-1 transmission and as possible components of HIV-1 vaccines should be pursued...
  39. doi Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Atlanta, Georgia 301333, USA
    Clin Infect Dis 50:1006-10. 2010
    ..Outbreaks of infection with hepatitis E virus (HEV) are frequently attributed to contaminated drinking water, even if direct evidence for this is lacking...
  40. pmc State plans for containment of pandemic influenza
    Scott D Holmberg
    Research Triangle Institute International, Atlanta, Georgia 30341 5533, USA
    Emerg Infect Dis 12:1414-7. 2006
    ..This review indicates the need for central planning for pandemic influenza and for epidemiologic studies regarding containment strategies in the community...
  41. ncbi Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients
    Kenneth A Lichtenstein
    Rose Medical Center, Unviersity of Colorado Health Sciences Center, Denver, Colorado 80220, USA
    J Acquir Immune Defic Syndr 32:48-56. 2003
    ..Some host factors and factors associated with previous or current severity of HIV infection, especially CD4 T-lymphocyte cell count, appeared to have the strongest association with incidence of lipoatrophy...
  42. ncbi Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort
    Kenneth A Lichtenstein
    Rose Medical Center, Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver 80262, USA
    Clin Infect Dis 40:148-57. 2005
    ..We sought to identify factors associated with the clinical diagnosis of symmetrical peripheral neuropathy (SPN) during the era of highly active antiretroviral therapy (HAART) in a retrospective, longitudinal cohort analysis...
  43. ncbi Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients
    Frank J Palella Jr
    Northwestern University Medical School, Chicago, Illinois 60611, USA
    AIDS 16:1617-26. 2002
    ..To evaluate the durability and correlates of the effectiveness of highly active antiretroviral therapy (HAART) in terms of AIDS-related mortality and morbidity, HIV viremia, and CD4 cell count...
  44. ncbi Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification
    Peter A Sklar
    Division of Infectious Dieseases, George Washington university and Dupont Circle Physicians Group, Washington, DC, USA
    AIDS 16:2035-41. 2002
    ..To examine the prevalence and clinical correlates of subsequently measurable viremia in HIV-infected patients who have achieved viral suppression below the limits of quantification (< 50 copies/ml)...
  45. ncbi Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy
    Ellen M Tedaldi
    Temple University Hospital, Section of General Internal Medicine, Philadelphia, Pennsylvania 19140, USA
    Clin Infect Dis 36:363-7. 2003
    ..HAART use was a strong predictor of increased duration of survival, suggesting that treatment is more important to survival than is HCV coinfection status...
  46. ncbi Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata
    Frank J Palella
    Division of Infectious Diseases, The Feinberg School of Medicine, Northwestern University, 676 North Saint Clair, Suite 200, Chicago, Illinois 60611, USA
    Ann Intern Med 138:620-6. 2003
    ..Optimal timing of antiretroviral therapy (ART) initiation for HIV-infected persons remains unclear...
  47. ncbi Trends in rates of myocardial infarction among patients with HIV
    Scott D Holmberg
    N Engl J Med 350:730-2; author reply 730-2. 2004
  48. ncbi Hepatitis A and B vaccination practices for ambulatory patients infected with HIV
    Ellen M Tedaldi
    General Internal Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA
    Clin Infect Dis 38:1478-84. 2004
    ....
  49. ncbi A 7-year longitudinal analysis of IL-2 in patients treated with highly active antiretroviral therapy
    Kenneth A Lichtenstein
    AIDS 18:2346-8. 2004
  50. ncbi Factors associated with chronic renal failure in HIV-infected ambulatory patients
    Christopher S Krawczyk
    School of Public Health, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    AIDS 18:2171-8. 2004
    ..We performed a cohort-based, nested case-control study to examine the role of several factors in developing HIV-related chronic renal disease, including HIV viral load and CD4+ cell count...
  51. ncbi Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohort
    Maria Deloria-Knoll
    Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    AIDS Patient Care STDS 18:721-7. 2004
    ....
  52. ncbi Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons
    Benjamin Young
    Rose Medical Center, Denver, Colorado, USA
    AIDS Patient Care STDS 20:238-44. 2006
    ....
  53. ncbi Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study
    Frank J Palella
    Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Acquir Immune Defic Syndr 43:27-34. 2006
    ..AIDS-related death and disease rates have declined in the highly active antiretroviral therapy (HAART) era and remain low; however, current causes of death in HAART-treated patients remain ill defined...
  54. ncbi Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients
    Ellen M Tedaldi
    Temple University School of Medicine, Philadelphia, PA 19140, USA
    J Acquir Immune Defic Syndr 43:35-41. 2006
    ....
  55. ncbi Migration patterns following HIV diagnosis among adults residing in the nonurban Deep South
    Bonita S Agee
    University of Alabama at Birmingham, School of Public Health, Birmingham, Alabama 35294 0022, USA
    AIDS Care 18:S51-8. 2006
    ..We conclude that most HIV transmission in non-urban Alabama and Mississippi is acquired locally. These results underline the need to expand HIV prevention programs in the Deep South...
  56. ncbi Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency
    Kenneth A Lichtenstein
    University of Colorado Health Sciences Center, Denver, CO, USA
    J Acquir Immune Defic Syndr 47:27-35. 2008
    ..US guidelines recommend deferring initiation of highly active antiretroviral therapy (HAART) for most patients with CD4 counts >350 cells/mm in part because of concerns about antiretroviral toxicity...
  57. doi HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care
    Lisa R Metsch
    Miller School of Medicine, University of Miami, Miami, Florida, USA
    Clin Infect Dis 47:577-84. 2008
    ..We examined the relationship between receipt of medical care for human immunodeficiency virus (HIV) infection and HIV transmission risk behavior among persons who had received a recent diagnosis of HIV infection...
  58. ncbi Protease inhibitor combination therapy and decreased condom use among gay men
    Ralph J Diclemente
    Emory University, Rollins School of Public Health and Emory Atlanta Center for AIDS Research, GA 30322, USA
    South Med J 95:421-5. 2002
    ..The objective of the study was to determine whether treatment with protease inhibitors is associated with unprotected sexual behavior...
  59. ncbi HIV and syphilis testing among men who have sex with men attending sex clubs and adult bookstores--San Francisco, 2003
    Kate A Buchacz
    J Acquir Immune Defic Syndr 37:1324-6. 2004